Lactated Ringer's solution versus saline fluid resuscitation for reducing PROGRESSION TO moderate-to-severe acute pancreatitis: a systematic review and meta-analysis.

IF 12.5 2区 医学 Q1 SURGERY
Tang Zhao, Zhiqiang Kang, Qiu Zhang, Feng Pu, Yun Zhang, Wen Qing Yin, Hong Ji Yang, Yu Zhou, Shi Kai Zhu
{"title":"Lactated Ringer's solution versus saline fluid resuscitation for reducing PROGRESSION TO moderate-to-severe acute pancreatitis: a systematic review and meta-analysis.","authors":"Tang Zhao, Zhiqiang Kang, Qiu Zhang, Feng Pu, Yun Zhang, Wen Qing Yin, Hong Ji Yang, Yu Zhou, Shi Kai Zhu","doi":"10.1097/JS9.0000000000002330","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fluid resuscitation represents a pivotal early therapeutic intervention in the management of acute pancreatitis (AP), yet a consensus on the optimal fluid type remains elusive. The present study endeavors to elucidate the differential effects of lactated Ringer's solution (LR) and normal saline (NS) in the initial treatment of AP.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted through the PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases, spanning from inception until July 2024. The primary outcome of interest was the likelihood of developing moderate-to-severe AP.</p><p><strong>Results: </strong>This meta-analysis synthesized evidence from six randomized controlled trials (RCTs) and four observational studies, involving a total of 1500 AP patients. Patients were stratified into two groups based on the administered fluid: LR (n = 689) and NS (n = 811). Our findings revealed that, compared to the NS group, patients in the LR group demonstrated a significantly lower risk of moderate-to-severe acute pancreatitis (OR 0.48; 95%Cl 0.34 to 0.67; P < 0.001; I2 = 0%), a shorter hospital stay (MD = - 0.74, 95% CI -1.20 to -0.28, P = 0.001; I2 = 0%), and a reduced ICU admission rate (RR = 0.42, 95% CI 0.20-0.89, P = 0.02; I2 = 0%). Moreover, the LR group also showed a lower incidence of local complications (RR = 0.58, 95% CI 0.34-0.98, P = 0.04). Conversely, no statistically significant differences were observed between the two groups in terms of mortality, organ failure rates, Fluid administered 24 h, systemic inflammatory response syndrome (SIRS).</p><p><strong>Conclusions: </strong>Our analysis underscores the superior efficacy of Lactated Ringer's (LR) solution in comparison to Normal Saline (NS). It provides compelling evidence of LR's ability to significantly mitigate the onset of moderate to severe pancreatitis. Additionally, our findings reveal that LR is associated with a reduced need for Intensive Care Unit (ICU) admissions, a lower incidence of local complications, and a shorter overall hospital stay, thereby offering a more favorable clinical outcome. However, no notable differences were discerned in other complications. Subgroup analyses further suggest LR's potential to curb pancreatic necrosis and other indices, albeit these findings necessitate corroboration through extensive experimentation.</p>","PeriodicalId":14401,"journal":{"name":"International journal of surgery","volume":" ","pages":""},"PeriodicalIF":12.5000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JS9.0000000000002330","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fluid resuscitation represents a pivotal early therapeutic intervention in the management of acute pancreatitis (AP), yet a consensus on the optimal fluid type remains elusive. The present study endeavors to elucidate the differential effects of lactated Ringer's solution (LR) and normal saline (NS) in the initial treatment of AP.

Methods: A comprehensive literature search was conducted through the PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases, spanning from inception until July 2024. The primary outcome of interest was the likelihood of developing moderate-to-severe AP.

Results: This meta-analysis synthesized evidence from six randomized controlled trials (RCTs) and four observational studies, involving a total of 1500 AP patients. Patients were stratified into two groups based on the administered fluid: LR (n = 689) and NS (n = 811). Our findings revealed that, compared to the NS group, patients in the LR group demonstrated a significantly lower risk of moderate-to-severe acute pancreatitis (OR 0.48; 95%Cl 0.34 to 0.67; P < 0.001; I2 = 0%), a shorter hospital stay (MD = - 0.74, 95% CI -1.20 to -0.28, P = 0.001; I2 = 0%), and a reduced ICU admission rate (RR = 0.42, 95% CI 0.20-0.89, P = 0.02; I2 = 0%). Moreover, the LR group also showed a lower incidence of local complications (RR = 0.58, 95% CI 0.34-0.98, P = 0.04). Conversely, no statistically significant differences were observed between the two groups in terms of mortality, organ failure rates, Fluid administered 24 h, systemic inflammatory response syndrome (SIRS).

Conclusions: Our analysis underscores the superior efficacy of Lactated Ringer's (LR) solution in comparison to Normal Saline (NS). It provides compelling evidence of LR's ability to significantly mitigate the onset of moderate to severe pancreatitis. Additionally, our findings reveal that LR is associated with a reduced need for Intensive Care Unit (ICU) admissions, a lower incidence of local complications, and a shorter overall hospital stay, thereby offering a more favorable clinical outcome. However, no notable differences were discerned in other complications. Subgroup analyses further suggest LR's potential to curb pancreatic necrosis and other indices, albeit these findings necessitate corroboration through extensive experimentation.

乳酸林格氏液与生理盐水复苏减少中重度急性胰腺炎进展:一项系统回顾和荟萃分析
背景:液体复苏是治疗急性胰腺炎(AP)的一项关键的早期治疗干预措施,但关于最佳液体类型的共识仍然难以捉摸。本研究试图阐明乳酸林格氏液(LR)和生理盐水(NS)在ap初始治疗中的不同作用。方法:通过PubMed、Embase和Cochrane中央对照试验注册(Central)数据库进行全面的文献检索,时间从建立到2024年7月。研究的主要结果是发生中度至重度AP的可能性。结果:该荟萃分析综合了来自6项随机对照试验(rct)和4项观察性研究的证据,共涉及1500名AP患者。根据给予的液体将患者分为两组:LR (n = 689)和NS (n = 811)。我们的研究结果显示,与NS组相比,LR组患者发生中重度急性胰腺炎的风险显著降低(OR 0.48;95%Cl = 0.34 ~ 0.67;P < 0.001;I2 = 0%),较短的住院(MD = - 0.74, 95%可信区间-1.20到-0.28,P = 0.001;I2 = 0%), ICU住院率降低(RR = 0.42, 95% CI 0.20-0.89, P = 0.02;i2 = 0%)。此外,LR组局部并发症发生率也较低(RR = 0.58, 95% CI 0.34 ~ 0.98, P = 0.04)。相反,两组在死亡率、器官衰竭率、输液24小时、全身炎症反应综合征(SIRS)方面没有统计学差异。结论:我们的分析强调了与生理盐水(NS)相比,乳酸林格氏液(LR)的疗效更好。它提供了令人信服的证据,证明LR能够显著减轻中度至重度胰腺炎的发病。此外,我们的研究结果显示,LR与重症监护病房(ICU)入院需求减少、局部并发症发生率降低和总住院时间缩短有关,从而提供了更有利的临床结果。然而,在其他并发症方面没有明显差异。亚组分析进一步表明,LR有抑制胰腺坏死和其他指标的潜力,尽管这些发现需要通过广泛的实验来证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
17.70
自引率
3.30%
发文量
0
审稿时长
6-12 weeks
期刊介绍: The International Journal of Surgery (IJS) has a broad scope, encompassing all surgical specialties. Its primary objective is to facilitate the exchange of crucial ideas and lines of thought between and across these specialties.By doing so, the journal aims to counter the growing trend of increasing sub-specialization, which can result in "tunnel-vision" and the isolation of significant surgical advancements within specific specialties.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信